APR 13, 2017 10:30 AM PDT

Why Variants Matter: NGS Bioinformatics Simplified for Oncology & Virology

Sponsored by: Vela Diagnostics
Speakers
  • Vice President of Precision Oncology, Vela Dx
    Biography
      Condie Carmack, Ph.D. received his Ph.D. from the University of Utah in Experimental Pathology and did postdocs in Philadelphia, PA and San Diego, CA. in mouse genetics and molecular biology. He is the author or or co-author of 23 peer-reviewed journal. He wrote the first paper on quantitative PCR and the second paper on multiplex PCR. He served on the Science Advisory Board of Life Technologies Inc. as an expert in clinical PCR. He was co-author on the first paper creating human monoclonal antibodies from immunodeficient mice. Mice serve as the foundation for creation of the current immune checkpoint blockade antibodies such as ipilimumab and nivolumab. He also served as General Manager of the Cancer Genetics Lab at Baylor College of Medicine before joining Vela Diagnostics
    • Director of Scientific Support for Vela Diagnostics, Bioinformatics Applications scientist
      Biography
        Ahmed Mahmoud is an experienced scientist with both hands-on lab and bioinformatics experience with degrees in both molecular biology and bioinformatics. Ahmed is currently the Director of Scientific Support for Vela Diagnostics as well as a Bioinformatics Applications scientist. Ahmed's team handles all technical wet lab and informatics support for Vela Diagnostic's qPCR and NGS workflows, assisting with pipeline creation for various NGS workflows and robotic application writing for automated systems. He has experience developing qPCR and Automated NGS workflows as well as extensive experience in NGS data analysis using multiple sequencing platforms. He has held positions in various areas of the biotech industry with institutions such as GeneDX, Pfizer and Columbia University Medical Center. Ahmed is also an avid iOS developer, creating computer apps geared towards the science sector.

      Abstract

      Next-generation sequencing is expected to take molecular diagnostics to the next level with the capability to perform deep analysis of genetic information that leads to targeted therapies perfectly matched to the situation. However, adoption of this technology in the clinic has been slower than expected due to various factors including ease-of-use, expense, footprint, and data complexity.  Today many of these hurdles have been overcome as NGS workflows have become increasingly automated, smaller, and less expensive.  For many in the clinic, the key to making this technology more accessible is automated bioinformatics that supports clinical decision-making.

      In this presentation we will delve into the sequencing world from the perspective of the variant.  We’ll uncover how today’s sophisticated bioinformatics engines can take raw sequencing data and transform the results into accurate and actionable reports that point to therapies and clinical trials.  We will explore this concept for clinical oncology and clinical virology and show how software today automates the process from sample-to -answer.


      Show Resources
      You May Also Like
      MAY 11, 2021 10:00 AM PDT
      C.E. CREDITS
      MAY 11, 2021 10:00 AM PDT
      Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
      JUN 09, 2021 7:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      JUN 09, 2021 7:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
      APR 01, 2021 8:00 AM PDT
      C.E. CREDITS
      APR 01, 2021 8:00 AM PDT
      Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
      APR 21, 2021 10:00 AM PDT
      C.E. CREDITS
      APR 21, 2021 10:00 AM PDT
      Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      DEC 15, 2020 10:00 AM PST
      C.E. CREDITS
      DEC 15, 2020 10:00 AM PST
      DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
      APR 13, 2017 10:30 AM PDT

      Why Variants Matter: NGS Bioinformatics Simplified for Oncology & Virology

      Sponsored by: Vela Diagnostics

      Specialty

      Antibodies

      Virology

      Immunology

      Dna Sequencing

      Cancer Diagnostics

      Bioinformatics

      Gene Expression

      Dna

      Cancer Research

      Biomarkers

      Gene Sequencing

      Cell Culture

      Biotechnology

      Dna Synthesis

      Molecular Genetics

      Geography

      Europe33%

      Africa33%

      Registration Source

      Website Visitors100%

      Job Title

      Student50%

      Educator/Faculty50%

      Organization

      Academic Institution33%

      Research Institute33%


      Show Resources
      Loading Comments...
      Show Resources
      Attendees
      • See more